Literature DB >> 1540844

Rat glioma cell lines C6 and 9L synthesize type 1 collagen in vitro.

A Ghahary1, R Bhatnagar, K Price, N L Forsyth, Y J Shen, T E Tredget, S K Malhotra.   

Abstract

Glial cell lines (C6, a glioma and 9L, a gliosarcoma) grown in vitro produce type 1 collagen which is detectable in the extracellular matrix by immunocytochemistry. Northern blot analysis using a cDNA specific for the proalpha2 (I) chain of procollagen indicates the presence of a single transcript with an apparent size of 4.8 kb in the C6 cell line, whereas two transcripts with apparent sizes of 5.8 and 4.8 kb are visualized in the 9L cells. The stimulatory effect of ascorbic acid on collagen production is detectable by a 20-27% increase in the concentration of hydroxyproline in the culture medium from the two glioma cell lines. Therefore these glioma cell lines provide a valuable model system for comparative investigations on the regulation of type 1 collagen synthesis by nonmesenchymal cells of neuroepithelial origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540844     DOI: 10.1016/0361-9230(92)90229-q

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  Characterization of integrin receptors in normal and neoplastic human brain.

Authors:  W Paulus; I Baur; D Schuppan; W Roggendorf
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 2.  The pathobiology of collagens in glioma.

Authors:  Leo S Payne; Paul H Huang
Journal:  Mol Cancer Res       Date:  2013-07-16       Impact factor: 5.852

3.  Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model.

Authors:  Tavarekere N Nagaraja; Rasha Elmghirbi; Stephen L Brown; Lonni R Schultz; Ian Y Lee; Kelly A Keenan; Swayamprava Panda; Glauber Cabral; Tom Mikkelsen; James R Ewing
Journal:  Magn Reson Imaging       Date:  2017-09-05       Impact factor: 2.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.